Search results for "hallucinogens"

showing 10 items of 28 documents

Role of nitric oxide pathway in the conditioned rewarding effects of MDMA in mice.

2017

It is estimated that 2.1 million young adults used MDMA/Ecstasy in the last year in Europe. Vulnerable subjects can develop dependence after MDMA abuse but currently there does not exist an effective treatment for this disorder. The nitric oxide (NO) pathway seems to have an important role on the rewarding effects of different drugs and has been proposed as a new pharmacological treatment for psychostimulant addiction. In the present study, we intend to evaluate whether the blockade of the NO synthesis (NOS) interferes with the rewarding effects of MDMA in the conditioned preference place (CPP) paradigm in young adult male mice. Our results indicated that mice treated with 7-nitroindazole (…

0301 basic medicineHallucinogenMaleMDMA7-NitroindazoleIndazolesmedia_common.quotation_subjectN-Methyl-34-methylenedioxyamphetamineEcstasyConditioning ClassicalEnsayos clínicosPharmacologyNitric OxideNitric oxide03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compoundMice0302 clinical medicineRewardmental disordersConditioning PsychologicalmedicineAnimalsDrogasmedia_commonbiologyAddictionMDMABlockadeNitric oxide synthaseEfectos fisiológicos030104 developmental biologychemistrybiology.proteinHallucinogensConditioning OperantCentral Nervous System StimulantsNitric Oxide SynthasePsychologyEstupefacientepsychological phenomena and processes030217 neurology & neurosurgerymedicine.drugBehavioural brain research
researchProduct

Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference.

2009

The present study employs a conditioned place preference procedure (CPP) to examine the effects of exposure to the cannabinoid agonist WIN 55212-2 (WIN) (0.1 and 0.5mg/kg) during adolescence on the reinforcing properties of +/-3,4-methylenedioxymetamphetamine hydrochloride (MDMA) (1.25 and 2.5mg/kg) in mice. On postnatal day (PD) 27, animals received a daily injection of the assigned treatment on 5 consecutive days, and three days later the place conditioning procedure was initiated (PD 35). The results suggest that pre-exposure to cannabinoids strengthens the properties of MDMA and favors reinstatement of the craving for the drug, which endorses the gateway hypothesis.

AgonistMaleReinforcement ScheduleTime Factorsmedicine.drug_classmedicine.medical_treatmentMorpholinesN-Methyl-34-methylenedioxyamphetamineSpatial BehaviorCravingPharmacologyNaphthalenesDevelopmental psychologyExtinction PsychologicalMiceRimonabantPiperidinesmedicineAnimalsDrug InteractionsCannabinoid Receptor AntagonistsBiological PsychiatryPharmacologyAnalysis of VarianceDose-Response Relationship DrugMDMAExtinction (psychology)Calcium Channel BlockersConditioned place preferenceBenzoxazinesAnimals NewbornHallucinogensCannabinoid receptor antagonistConditioning OperantPyrazolesCannabinoidmedicine.symptomRimonabantPsychologypsychological phenomena and processesmedicine.drugProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice

2015

The pharmacological activities and acute toxicity of the psilocin (PC) and dried residues of the crude extracts of psychotropic mushrooms were investigated in mice. The hallucinogenic substances were effectively isolated, by using methanol, from the species of Psilocybe semilanceata and Pholiotina cyanopus, that were collected in the north-east region of Poland. The chemical analysis of these extracts, which was performed by liquid chromatography with mass spectrometry detection (LC-MS), indicated the presence of psilocin and other hallucinogenic substances, including indolealkylamines and their phosphorylated analogues. When the pure psilocin or fungal extracts were used, slight difference…

Agonistmedicine.drug_classHealth Toxicology and Mutagenesislcsh:Medicineacute toxicityComplex MixturesPharmacologyToxicologyhead-twitch response (HTR)Median lethal dosePartial agonistArticlePsilocybinLethal Dose 50MiceAnimals Outbred StrainsmedicineAnimalspsilocybin mushrooms; psilocin; acute toxicity; head-twitch response (HTR)psilocinBehavior AnimalbiologyChemistryMethanollcsh:Rpsilocybin mushroomsbiology.organism_classificationAcute toxicityPsilocybin<i>head-twitch</i> response (HTR)PsilocinToxicityHallucinogensSolventsPsilocybe semilanceataFemaleAgaricalesmedicine.drugToxins
researchProduct

Determination of muscimol and ibotenic acid in mushrooms of Amanitaceae by capillary electrophoresis

2014

In this study, the CZE method for rapid quantitative and qualitative determination of ibotenic acid and muscimol in Amanita mushrooms naturally grown in Poland was developed. The investigations included the species of A. muscaria, A. pantherina, and A. citrina, collected in southern region of Poland. The studied hallucinogenic compounds were effectively extracted with a mixture of methanol and 1 mM sodium phosphate buffer at pH 3 (1:1 v/v) using ultrasound-assisted procedure. The obtained extracts were separated and determined by CZE utilizing a 25 mM sodium phosphate running buffer adjusted to pH 3 with 5% content of acetonitrile v/v. The calibration curves for both analytes were linear in…

AmanitaamanitaceaeSodiumAmanitaClinical Biochemistrycapillary electrophoresischemistry.chemical_elementBiochemistryAnalytical Chemistrychemistry.chemical_compoundCapillary electrophoresisLimit of DetectionAmanitaceaeChromatographybiologyChemistryElectrophoresis CapillaryReproducibility of Resultsbiology.organism_classificationPhosphateibotenic acidmuscimolMuscimolLinear ModelshallucinogensMethanolIbotenic acidElectrophoresis
researchProduct

Sensitive determination of methylenedioxylated amphetamines by liquid chromatography.

2001

Different strategies for the liquid chromatographic determination of methylenedioxylated amphetamines were evaluated: separation and detection of underivatized analytes by (i) UV or (ii) fluorescence, (iii) derivatization with 3,5-dinitrobenzoyl chloride followed by separation and UV detection of the derivatives formed and (iv) derivatization with 9-fluorenylmethyl chloroformate (FMOC) and subsequent separation and fluorimetric detection of the derivatives. The compounds tested were 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethylamphetamine (MDE). On the basis of these studies, a new procedure for the chromatographic determination of…

Detection limitReproducibilityAnalyteChromatographyChemistryN-Methyl-34-methylenedioxyamphetamineAmphetaminesChloroformateBiochemistryFluorescence spectroscopyAnalytical Chemistrychemistry.chemical_compoundElectrochemistryHallucinogensEnvironmental ChemistryHumansUv detectionDerivatizationQuantitative analysis (chemistry)Spectroscopy34-MethylenedioxyamphetamineChromatography LiquidThe Analyst
researchProduct

Effects of acute social stress on the conditioned place preference induced by MDMA in adolescent and adult mice

2014

Exposure to social defeat stress increases the rewarding effects of psychostimulants in animal models, but its effect on 3,4-methylenedioxymethylamphetamine (MDMA) reward has received little attention. In the present study, we evaluated the influence of social defeat on the rewarding effects of MDMA in adolescent [postnatal day (PND) 29-40] and adult (PND 50-61) male mice using the conditioned place preference paradigm. Experimental mice were exposed to social defeat in an agonistic encounter before each session of conditioning with 1.25 or 10 mg/kg of MDMA. The effects of social defeat on corticosterone levels and the motor or the anxiogenic effects of MDMA were also evaluated. Mice expose…

Dominance-SubordinationMaleAgingmedicine.medical_specialtyN-Methyl-34-methylenedioxyamphetamineAnxietyMotor ActivityAffect (psychology)Social defeatMicechemistry.chemical_compoundRewardCorticosteroneInternal medicineConditioning Psychologicalmental disordersmedicineAgonistic behaviourAnimalsSocial BehaviorPharmacologySocial stressDose-Response Relationship Drugbusiness.industryMDMAConditioned place preferencePsychiatry and Mental healthEndocrinologychemistryAnxiogenicSpace PerceptionHallucinogensCorticosteronebusinessStress Psychologicalpsychological phenomena and processesmedicine.drugBehavioural Pharmacology
researchProduct

Cognitive and behavioural effects induced by social stress plus MDMA administration in mice

2017

Adverse life experiences such as social stress may make an individual more vulnerable to drug addiction and mental disorders associated with drug consumption. The present work aimed to evaluate the effects of stress induced by acute social defeat combined with the administration of 3,4-methylenedioxymethamphetamine (MDMA) on depression-like behaviour, memory function and motor response to drug in late adolescent male mice. Two groups of mice were exposed to social defeat (SD) during four encounters with an aggressive co-specific, which took place on alternate days. Immediately after defeat, animals were treated with saline or MDMA 10mg/kg (SD+SAL and SD+MDMA). In control groups, mice were p…

Dominance-SubordinationMalemedicine.medical_specialtyN-Methyl-34-methylenedioxyamphetaminemedia_common.quotation_subjectPoison controlBehavioral SymptomsMotor ActivityBody TemperatureSocial defeatMice03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicineCorticosteroneInternal medicinemental disordersAvoidance LearningmedicineAnimalsPsychiatrymedia_commonSocial stressAnalysis of VarianceAddictionRecognition PsychologyMDMAmedicine.diseaseTail suspension test030227 psychiatrySubstance abuseDisease Models AnimalEndocrinologyHindlimb SuspensionchemistryHallucinogensCognition DisordersCorticosteronePsychologyStress Psychologicalpsychological phenomena and processes030217 neurology & neurosurgerymedicine.drugBehavioural Brain Research
researchProduct

False-positive LSD testing in urine samples from intensive care patients.

1998

Unexpected positive results for lysergic acid diethylamide (LSD) were found in urine samples from 12 patients in an intensive care unit in a routine screening using the CEDIA DAU assay. None of these test results could be confirmed by high-performance liquid chromatography analysis, but all samples contained the mucolytic drug ambroxol. Further studies demonstrated that ambroxol exhibits a significant cross-reactivity in the CEDIA DAU LSD assay. Therefore, positive LSD results obtained with the CEDIA DAU assay have to be critically evaluated, particularly during the cold season, when infections of the respiratory tract often result in more frequent use of mucolytic medications.

HallucinogenAdultMalemedicine.medical_specialtyHealth Toxicology and MutagenesisAmbroxolUrineCross ReactionsToxicologyHigh-performance liquid chromatographyGastroenterologyAnalytical Chemistrylaw.inventionlawIntensive careInternal medicinemedicineEnvironmental ChemistryHumansFalse Positive ReactionsChromatography High Pressure LiquidLysergic acid diethylamideAgedExpectorantsAged 80 and overImmunoassayChemical Health and SafetyChromatographymedicine.diagnostic_testChemistryIntensive care unitAmbroxolIntensive Care UnitsLysergic Acid DiethylamideImmunoassayHallucinogensFemaleReagent Kits Diagnosticmedicine.drugJournal of analytical toxicology
researchProduct

Binge administration of 3,4-methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus.

2006

3,4-Methylenedioxymethamphetamine (MDMA) is a potent stimulant and hallucinogenic drug whose ability to regulate neurogenesis in the adult has not been previously investigated. We used 5'-bromo-2-deoxyuridine (BrdU) and Ki-67 as mitotic markers, and doublecortin (DCX) as a marker of immature neurons, to study proliferation, survival and maturation of adult-generated cells in the dentate gyrus (DG) of the hippocampus following binge administration of MDMA (8 injections of 5 mg/kg at 6 h intervals). The results showed that MDMA treatment did not affect cytogenesis in the DG, but significantly decreased the survival rate of cells incorporated after 2 weeks to the granular layer of the DG by ca…

HallucinogenDoublecortin Domain ProteinsMalemedicine.medical_specialtyDoublecortin ProteinCell SurvivalN-Methyl-34-methylenedioxyamphetamineHippocampusCellular and Molecular NeuroscienceInternal medicinemedicineAnimalsProgenitor cellRats WistarPharmacologyNeuronsAnalysis of VariancebiologyBehavior AnimalDentate gyrusStem CellsNeurogenesisNeuropeptidesColocalizationMDMACell DifferentiationImmunohistochemistryDoublecortinRatsEndocrinologyKi-67 Antigennervous systemBromodeoxyuridineDentate Gyrusbiology.proteinHallucinogensNeuroscienceMicrotubule-Associated Proteinsmedicine.drugNeuropharmacology
researchProduct

Mannitol in Amanita muscaria – An osmotic blood–brain barrier disruptor enhancing its hallucinogenic action?

2013

Hypothesis have been made that relatively high level of mannitol present in the tissues of fly agaric (Amanita muscaria) enables more efficient transportation of these active substances into the brain and thus enhance their total activity. It may have been supported by the fact that hallucinogenic effect after A. muscaria consumption is greater than after ingestion of an active substance quantity which the eaten fungi dose contain.

HallucinogenMagnetic Resonance SpectroscopyInjury controlAmanitaPoison controlComplex MixturesPharmacologyBlood–brain barrierToxicologyOsmoregulationSpecies SpecificityHumansMedicineIngestionMannitolbiologybusiness.industryAgaricBrainGeneral Medicinebiology.organism_classificationmedicine.anatomical_structureHallucinogensMannitolbusinessAmanita muscariamedicine.drugMedical Hypotheses
researchProduct